Quote | Super Quote
IPO   |   IPO News   |   Listed IPO Information   |   Hot Listed IPO
Stock Code   IPO News IPO Timetable
IPO Detail
02522 一脈陽光
RIMAG GROUP
Listing Date2024/06/07
Listing Price14.980
 
Quote
Subscription Result
  • Subscription Rate
    336.33x
  • Guarantee One Lot Size
    60 lot
  • One Lot Success Rate
    3.01%
COMPANY PROFILE

Jiangxi Rimag Group is a leading medical group specialized in medical imaging in China. It has created integrated one-stop business network centered around its imaging center services, imaging solution services and Rimag Cloud services.

--

According to report, the Group accounted for approximately 1.1% of the PRC medical imaging service market in 2023. In 2023, it ranked first among all PRC third-party medical imaging center operators; in terms of revenue generated from imaging center services in 2023, it ranked second among all PRC third-party medical imaging center operators.

--

The Group have generated the majority of its revenue from provision of imaging center services. Its medical imaging center network consisted of 97 imaging centers, including: nine flagship imaging centers; 24 regional collaborative imaging centers; 50 specialized medical consortium imaging centers; and 14 operational management —imaging centers as of December 31, 2023.

--

The Group’s customers primarily include public and private medical institutions and healthcare companies.

BASIC INFORMATION
MarketHong Kong (Main Board)
Business NatureHealth Care
Major Business AreaChina
Board Lot500
GLOBAL OFFERING
No. of Offer Shares17.82M H shares
No. of International Offer Shares8.91M H shares
No. of HK Offer Shares8.91M H shares
Offer Price$14.60 - $16.80
Stock Code2522
Sponsor(s)CITIC Securities (Hong Kong) Limited
Underwriter(s)CLSA Limited, CMB International Capital Limited, Huatai Financial Holdings (Hong Kong) Limited, Fosun International Securities Limited, ABCI Securities Company Limited, China Galaxy International Securities (Hong Kong) Co., Limited, Futu Securities International (Hong Kong) Limited, ICBC International Securities Limited, Patrons Securities Limited, Quam Securities Limited, SPDB International Capital Limited, TradeGo Markets Limited, Victoria Harbour International Financial Holdings Limited, Yue Xiu Securities Company Limited, Zhongtai International Securities Limited
TIME TABLE
Application PeriodMay 30 (Thu) - noon, Jun 04 (Tue)
Price Determination DateJun 05 (Wed)
Result Announcement DateOn or before Jun 06 (Thu)
Result Announcement DateOn or before Jun 06 (Thu)
Result Announcement DateOn or before Jun 07 (Fri)
Dealings in Shares commence onJun 07, 2024. (Fri)
Reallocation of Shares Offered
Times of HK Offer Shares Subscription15X - 50X50X - 100XOver 100X
% of total shares reallocated to HK Offer30%40%50%
Sales Statistics (HKD)
Offer Price$14.60 - $16.80
Capitalization5.20B - 5.99B
NAV / share ($)$4.44 - $4.55 (Unaudited pro forma adj NAV / share)
Use Of Proceeds
Assuming the offer price being at HKD 15.7, the net proceeds raised would be HKD 223.80M, of which
50% : Expanding medical imaging center network
20% : Pursuing strategic cooperation and mergers and acquisitions
20% : Extending business to overseas countries and regions
10% : Working capital
Related Document
Remark: The above information is referenced from the prospectus.
  All data is calculated from the non- exercise rights(if applicable).
IPO Calculator
Name︰
--
--
--
Subscription --
Result Announcement --
Listing --
Offer Price︰--
Currency :
Listing Price :
Board Lot :
Admission Fee*
:
Subscribing Lot :
Subscribing Fee :

Subscribing Amount :
*Admission fees include brokerage of 1%, SFC transaction levy of 0.0027%, Stock Exchange trading fee of 0.005% and FRC transaction levy of 0.00015% (i.e. 1.0077% in total).
A Member of HKET Holdings
Customer Service Hotline:(852) 2880 7004     Customer Service Email:cs@etnet.com.hk
Copyright 2024 ET Net Limited. http://www.etnet.com.hk ET Net Limited, HKEx Information Services Limited, its Holding Companies and/or any Subsidiaries of such holding companies, and Third Party Information Providers endeavour to ensure the availability, completeness, timeliness, accuracy and reliability of the information provided but do not guarantee its availability, completeness, timeliness, accuracy or reliability and accept no liability (whether in tort or contract or otherwise) any loss or damage arising directly or indirectly from any inaccuracies, interruption, incompleteness, delay, omissions, or any decision made or action taken by you or any third party in reliance upon the information provided. The quotes, charts, commentaries and buy/sell ratings on this website should be used as references only with your own discretion. ET Net Limited is not soliciting any subscriber or site visitor to execute any trade. Any trades executed following the commentaries and buy/sell ratings on this website are taken at your own risk for your own account.